Results 11 to 20 of about 25,411 (289)

A Randomized, Open-Label Study to Assess Efficacy of Weekly Assumption of Cholecalciferol versus Calcifediol in Older Patients with Hypovitaminosis D

Geriatrics, 2022
The aim of this single-center, open-label, randomized controlled study was to evaluate which formulation of vitamin D—between cholecalciferol and calcifediol—is most effective in the treatment of hypovitaminosis D in older adults.
Chukwuma Okoye, Valeria Calsolaro, Filippo Niccolai, Alessia Maria Calabrese, Riccardo Franchi, Sara Rogani, Giulia Coppini, Virginia Morelli, Nadia Caraccio, Fabio Monzani   +9 more
doaj   +2 more sources

Persistent Increase in Serum 25-Hydroxyvitamin D Concentration in a Dog Following Cholecalciferol Intoxication

Frontiers in Veterinary Science, 2020
Cholecalciferol is becoming an increasingly utilized rodenticide in the United States due to changes implemented by the Environmental Protection Agency (EPA) to reduce unintended exposure of wildlife to second-generation anticoagulant rodenticides.
Charlotte Gerhard, Jared A. Jaffey
doaj   +2 more sources

Cholecalciferol [PDF]

Pharmacy Today, 2020
A steroid hormone produced in the skin when exposed to ultraviolet light or obtained from dietary sources. T he active form of cholecalciferol, 1,25-dihydroxycholecalciferol (calcitriol) plays an important role in maintaining blood calcium and phosphorus
semanticscholar   +3 more sources

Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly

Journal of Clinical Endocrinology and Metabolism, 2023
Context Skeletal fragility is observed in 30% to 60% of acromegaly patients, representing an emerging complication of the disease that increases disability.
S. Chiloiro, S. Frara, I. Gagliardi, A. Bianchi, A. Giampietro, Margherita Medici, A. Allora, L. di Filippo, M. Ambrosio, A. Pontecorvi, M. Zatelli, L. De Marinis, A. Giustina   +12 more
semanticscholar   +1 more source

A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D—a randomised multicentre international clinical trial

BMC Medicine, 2022
Background Vitamin D status has been implicated in COVID-19 disease. The objective of the COVID-VIT-D trial was to investigate if an oral bolus of cholecalciferol (100,000 IU) administered at hospital admission influences the outcomes of moderate-severe ...
J. Cannata-Andía, Augusto Díaz-Sottolano, P. Fernández, Carmen Palomo-Antequera, P. Herrero-Puente, R. Mouzo, N. Carrillo-López, Sara Panizo, Guillermo H. Ibañez, Carlos A. Cusumano, C. Ballarino, Vicente Sánchez-Polo, Jacqueline Pefaur-Penna, Irene Maderuelo-Riesco, Jesús Calviño-Varela, M. D. Gómez, C. Gómez-Alonso, J. Cunningham, M. Naves-Díaz, W. Douthat, J. Fernández-Martín   +20 more
semanticscholar   +1 more source

High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3–4: results of a 12-week double-blind, randomized, controlled study [PDF]

Nephrology, Dialysis and Transplantation, 2017
Background Calcidiol insufficiency may accelerate the development of secondary hyperparathyroidism (SHPT). We tested the effect of a substantial increase in calcidiol on mineral metabolism in patients with chronic kidney disease (CKD).
Per-Anton Westerberg, Gunnar Sterner, Östen Ljunggren, Elin Isaksson, Fjölnir Elvarson, Hamid Dezfoolian, Torbjörn Linde   +6 more
openalex   +2 more sources

Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study

Nutrients, 2022
Recent studies showed that a low 25-hydroxyvitamin D (25(OH)D) level was associated with a higher risk of morbidity and severe course of COVID-19. Our study aimed to evaluate the effects of cholecalciferol supplementation on the clinical features and ...
Tatiana L Karonova, K. A. Golovatyuk, I. Kudryavtsev, A. Chernikova, A. A. Mikhaylova, A. Aquino, D. Lagutina, E. Zaikova, O. V. Kalinina, A. Golovkin, W. Grant, E. Shlyakhto   +11 more
semanticscholar   +1 more source

Cholecalciferol complexation with hydroxypropyl-β-cyclodextrin (HPBCD) and its molecular dynamics simulation

Pharmaceutical development and technology (Print), 2022
The focus of the current study is to investigate cholecalciferol (vitamin D3) solubilization by hydroxypropyl-β-cyclodextrin (HPBCD) complexation through experimental and computational studies. Phase solubility diagram of vitamin D3 (completely insoluble
Fang Wang, Wenbo Yu, C. Popescu, Ahmed Ibrahim, Dongyue Yu, Ryan M Pearson, A. MacKerell, S. Hoag   +7 more
semanticscholar   +1 more source

Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential cardioprotective mechanisms of vitamin D?

Nutrition and Metabolism, 2022
Background Vitamin D deficiency is one of the most common health issues in developed countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D 3 (25(OH)D 3 ) levels that are too low due to the accumulation of vitamin D in adipose ...
Mateusz Ozorowski, Michał Wiciński, Łukasz Wróbel, Anna Fajkiel-Madajczyk   +3 more
semanticscholar   +1 more source

Complications after medullary thyroid carcinoma surgery: multicentre study of the SQRTPA and EUROCRINE® databases

BJS (British Journal of Surgery), EarlyView., 2020
This study investigated postoperative complications after surgery for medullary thyroid carcinoma (MTC) in Europe. Hypoparathyroidism, recurrent laryngeal nerve palsy and bleeding requiring reoperation occurred in 170 (26·2 per cent), 62 (13·7 per cent) and 17 (2·6 per cent) patients respectively.
D.‐J. van Beek, M. Almquist, A. O. Bergenfelz, T. J. Musholt, E. Nordenström, on behalf of the EUROCRINE® Council, M. Almquist, M. Barczynski, L. Brunaud, T. Clerici, M. H. Hansen, M. Iacobone, Ö. Makay, F. F. Palazzo, N. Muñoz‐Pérez, M. Raffaelli, P. Riss, S. van Slycke, M. R. Vriens   +18 more
wiley   +1 more source